Search

Your search keyword '"Soldato, Davide"' showing total 40 results
Start Over Author "Soldato, Davide"
40 results on '"Soldato, Davide"'

1. Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis

Author

Vaz-Luis, Ines, Di Meglio, Antonio, Havas, Julie, El-Mouhebb, Mayssam, Lapidari, Pietro, Presti, Daniele, Soldato, Davide, Pistilli, Barbara, Dumas, Agnes, Menvielle, Gwenn, Charles, Cecile, Everhard, Sibille, Martin, Anne-Laure, Cottu, Paul H, Lerebours, Florence, Coutant, Charles, Dauchy, Sarah, Delaloge, Suzette, Lin, Nancy U, Ganz, Patricia A, Partridge, Ann H, André, Fabrice, and Michiels, Stefan

Subjects
Prevention, Clinical Research, Cancer, Breast Cancer, Rehabilitation, Breast Neoplasms, Fatigue, Female, Humans, Longitudinal Studies, Patient Reported Outcome Measures, Prospective Studies, Quality of Life, Survivors, Clinical Sciences, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

PurposeFatigue is recognized as one of the most burdensome and long-lasting adverse effects of cancer and cancer treatment. We aimed to characterize long-term fatigue trajectories among breast cancer survivors.MethodsWe performed a detailed longitudinal analysis of fatigue using a large ongoing national prospective clinical study (CANcer TOxicity, ClinicalTrials.gov identifier: NCT01993498) of patients with stage I-III breast cancer treated from 2012 to 2015. Fatigue was assessed at diagnosis and year 1, 2, and 4 postdiagnosis. Baseline clinical, sociodemographic, behavioral, tumor-related, and treatment-related characteristics were available. Trajectories of fatigue and risk factors of trajectory-group membership were identified by iterative estimates of group-based trajectory models.ResultsThree trajectory groups were identified for severe global fatigue (n = 4,173). Twenty-one percent of patients were in the high-risk group, having risk estimates of severe global fatigue of 94.8% (95% CI, 86.6 to 100.0) at diagnosis and 64.6% (95% CI, 59.2 to 70.1) at year 4; 19% of patients clustered in the deteriorating group with risk estimates of severe global fatigue of 13.8% (95% CI, 6.7 to 20.9) at diagnosis and 64.5% (95% CI, 57.3 to 71.8) at year 4; 60% were in the low-risk group with risk estimates of 3.6% (95% CI, 2.5 to 4.7) at diagnosis and 9.6% (95% CI, 7.5 to 11.7) at year 4. The distinct dimensions of fatigue clustered in different trajectory groups than those identified by severe global fatigue, being differentially affected by sociodemographic, clinical, and treatment-related factors.ConclusionOur findings highlight the multidimensional nature of cancer-related fatigue and the complexity of its risk factors. This study helps to identify patients with increased risk of severe fatigue and to inform personalized interventions to ameliorate this problem.

Published
2022

2. Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care

Author

Di Meglio, Antonio, Havas, Julie, Soldato, Davide, Presti, Daniele, Martin, Elise, Pistilli, Barbara, Menvielle, Gwenn, Dumas, Agnes, Charles, Cecile, Everhard, Sibille, Martin, Anne-Laure, Coutant, Charles, Tarpin, Carole, Vanlemmens, Laurence, Levy, Christelle, Rigal, Olivier, Delaloge, Suzette, Lin, Nancy U, Ganz, Patricia A, Partridge, Ann H, André, Fabrice, Michiels, Stefan, and Vaz-Luis, Ines

Subjects
Behavioral and Social Science, Clinical Research, Breast Cancer, Cancer, Prevention, Good Health and Well Being, Breast Neoplasms, Cancer Survivors, Female, Humans, Quality of Life, Survivors, Survivorship, Clinical Sciences, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

PurposeFatigue is common and troublesome among breast cancer survivors; however, limited tools exist to predict its risk.Patients and methodsParticipants with stage I-III breast cancer were prospectively included from CANTO (ClinicalTrials.gov identifier: NCT01993498), collecting longitudinal data at diagnosis (before the initiation of any cancer treatment) and 1 (T1), 2 (T2), and 4 (T3) years after diagnosis. The main outcome was severe global fatigue at T2 (score ≥ 40/100, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-C30). Analyses at T3 were exploratory. Secondary outcomes included physical, emotional, and cognitive fatigue (EORTC Quality of Life Questionnaire-FA12). Multivariable logistic regression models retained associations with severe fatigue by bootstrapped Augmented Backward Elimination. Validation methods included 10-fold internal cross-validation, overoptimism-corrected area under the receiver operating characteristic curves, and external validation.ResultsAmong 5,640, 5,000, and 3,400 patients at T1, T2, and T3, respectively, the prevalence of post-treatment severe global fatigue was 35.6%, 34.0%, and 31.5% in the development cohort. Retained risk factors for severe global fatigue at T2 were severe pretreatment fatigue (adjusted odds ratio v no 3.191 [95% CI, 2.704 to 3.767]); younger age (for 1-year decrement 1.015 [1.009 to 1.022]), higher body mass index (for unit increment 1.025 [1.012 to 1.038]), current smoking behavior (v never 1.552 [1.291 to 1.866]), worse anxiety (v noncase 1.265 [1.073 to 1.492]), insomnia (for unit increment 1.005 [1.003 to 1.007]), and pain at diagnosis (for unit increment 1.014 [1.010 to 1.017]), with an area under the receiver operating characteristic curve of 0.73 (95% CI, 0.72 to 0.75). Receipt of hormonal therapy was a risk factor for severe fatigue at T3 (v no 1.448 [1.165 to 1.799]). Dimension-specific risk factors included body mass index for physical fatigue and emotional distress for emotional and cognitive fatigue.ConclusionWe propose a predictive model to assess fatigue among breast cancer survivors, within a personalized survivorship care framework. This may help clinicians to provide early management interventions or to correct modifiable risk factors and offer more tailored monitoring and education to patients at risk of severe post-treatment fatigue.

Published
2022

4. Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

Author

Auclin, Edouard, Benitez-Montanez, Jose, Tagliamento, Marco, Parisi, Francesca, Gorria, Teresa, Garcia-Campelo, Rosario, Dempsey, Naomi, Pinato, David J., Reyes, Roxana, Albarrán-Artahona, Víctor, Dall'Olio, Filippo, Soldato, Davide, Hendriks, Lizza, Nana, Frank Aboubakar, Tonneau, Marion, Lopez-Castro, Rafael, Nadal, Ernest, Kazandjian, Suzanne, Muanza, Thierry, Blanc-Durand, Félix, Fabre, Elizabeth, Castro, Natalia, Arasanz, Hugo, Rochand, Adrien, Besse, Benjamin, Routy, Bertrand, and Mezquita, Laura

Published
2023
Full Text
View/download PDF

5. Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer

Author

Soldato, Davide, primary, Michiels, Stefan, additional, Havas, Julie, additional, Di Meglio, Antonio, additional, Pagliuca, Martina, additional, Franzoi, Maria Alice, additional, Pistilli, Barbara, additional, Iyengar, Neil M., additional, Cottu, Paul, additional, Lerebours, Florence, additional, Coutant, Charles, additional, Bertaut, Aurélie, additional, Tredan, Oliver, additional, Vanlemmens, Laurence, additional, Jouannaud, Christelle, additional, Hrab, Iona, additional, Everhard, Sibille, additional, Martin, Anne-Laure, additional, André, Fabrice, additional, Vaz-Luis, Ines, additional, and Jones, Lee W., additional

Published
2024
Full Text
View/download PDF

8. Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients

Author

Puccini, Alberto, Seeber, Andreas, Xiu, Joanne, Goldberg, Richard M., Soldato, Davide, Grothey, Axel, Shields, Anthony F., Salem, Mohamed E., Battaglin, Francesca, Berger, Martin D., El-Deiry, Wafik S., Tokunaga, Ryuma, Naseem, Madiha, Zhang, Wu, Arora, Sukeshi Patel, Khushman, Moh’d M., Hall, Michael J., Philip, Philip A., Marshall, John L., Korn, W. Michael, and Lenz, Heinz-Josef

Published
2021
Full Text
View/download PDF

10. The Future of Breast Cancer Research in the Survivorship Field

Author

Soldato, Davide, Arecco, Luca, Agostinetto, Elisa, Franzoi, Maria Alice, Mariamidze, Elene, Begijanashvili, Salome, Brunetti, Nicole, Spinaci, Stefano, Solinas, Cinzia, Vaz-Luis, Ines, Di Meglio, Antonio, Lambertini, Matteo Md Phd M., Soldato, Davide, Arecco, Luca, Agostinetto, Elisa, Franzoi, Maria Alice, Mariamidze, Elene, Begijanashvili, Salome, Brunetti, Nicole, Spinaci, Stefano, Solinas, Cinzia, Vaz-Luis, Ines, Di Meglio, Antonio, and Lambertini, Matteo Md Phd M.

Abstract

Prevalence of survivors of breast cancer has been steadily increasing in the last 20 years. Currently, more than 90% of women diagnosed with early-stage breast cancer are expected to be alive at 5 years from diagnosis thanks to early detection and breakthrough innovations in multimodal treatment strategies. Alongside this advancement in clinical outcomes, survivors of breast cancer might experience several specific challenges and present with unique needs. Survivorship trajectories after diagnosis and treatment of breast cancer can be significantly impacted by long-lasting and severe treatment-related side effects, including physical problems, psychological distress, fertility issues in young women, and impaired social and work reintegration, which add up to patients’ individual risk of cancer recurrence and second primary malignancies. Alongside cancer-specific sequelae, survivors still present with general health needs, including management of chronic preexisting or ensuing conditions. Survivorship care should implement high-quality, evidence-based strategies to promptly screen, identify, and address survivors’ needs in a comprehensive way and minimize the impact of severe treatment sequelae, preexisting comorbidities, unhealthy lifestyles, and risk of recurrence on quality of life. This narrative review focuses on core areas of survivorship care and discuss the state of the art and future research perspectives in key domains including selected long-term side effects, surveillance for recurrences and second cancers, well-being promotion, and specific survivors’ needs., SCOPUS: re.j, info:eu-repo/semantics/published

Published
2023

11. PROACT: Implementing a PROACTive care pathway to empower and support breast cancer (BC) survivors.

Author

Franzoi, Maria Alice B, primary, Degousee, Lena, additional, Martin, Elise, additional, Aupomerol, Marion, additional, Soldato, Davide, additional, Di Meglio, Antonio, additional, Barbier, Aude, additional, Lazorthes, Celine, additional, Chaouachi, Hajer, additional, Renvoise, Nathalie, additional, Boinon, Diane, additional, Fasse, Leonor, additional, Le-Provost, Jean Bernard, additional, Arvis, Johanna, additional, De-Jesus, Anne, additional, Raynard, Bruno, additional, Delaloge, Suzette, additional, Pistilli, Barbara, additional, Scotte, Florian, additional, and Luis, Ines Maria Vaz Duarte, additional

Published
2022
Full Text
View/download PDF

12. Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer.

Author

Franzoi, Maria Alice, Degousée, Lena, Martin, Elise, Miguel Semedo, Patricia, Aupomerol, Marion, Soldato, Davide, Di Meglio, Antonio, Chiodi, Camila, Barbier, Aude, Chaouachi, Hajer, Renvoisé, Nathalie, Boinon, Diane, Fasse, Léonor, Ribeiro, Joana, Bernard Le-Provost, Jean, Arvis, Johanna, Lazorthes, Céline, di Palma, Mario, de Jesus, Anne, and Raynard, Bruno

Subjects
PILOT projects, SOCIAL support, EVALUATION of human services programs, FOCUS groups, MOBILE apps, ATTITUDES of medical personnel, INDIVIDUALIZED medicine, PATIENT satisfaction, CANCER patients, SELF-efficacy, ONCOLOGY, HUMAN services programs, QUALITATIVE research, MEDICAL protocols, PATIENTS' attitudes, HEALTH care teams, DESCRIPTIVE statistics, PATIENT education, THEMATIC analysis, DATA analysis software, BREAST tumors, HEALTH self-care
Abstract

PURPOSE: Optimal comprehensive survivorship care is insufficiently delivered. To increase patient empowerment and maximize the uptake of multidisciplinary supportive care strategies to serve all survivorship needs, we implemented a proactive survivorship care pathway for patients with early breast cancer at the end of primary treatment phase. METHODS: Pathway components included (1) a personalized survivorship care plan (SCP), (2) face-to-face survivorship education seminars and personalized consultation for supportive care referrals (Transition Day), (3) a mobile app delivering personalized education and self-management advice, and (4) decision aids for physicians focused on supportive care needs. A mixed-methods process evaluation was performed according to the Reach, Effectiveness, Adoption, Implementation and Maintenance framework including administrative data review, pathway experience survey (patient, physician, and organization), and focus group. The primary objective was patient-perceived satisfaction with the pathway (predefined progression criteria for pathway continuation ≥70%). RESULTS: Over 6 months, 321 patients were eligible for the pathway and received a SCP and 98 (30%) attended the Transition Day. Among 126 patients surveyed, 77 (66.1%) responded. 70.1% received the SCP, 51.9% attended the Transition Day, and 59.7% accessed the mobile app. 96.1% of patients were very or completely satisfied with the overall pathway, whereas perceived usefulness was 64.8% for the SCP, 90% for the Transition Day, and 65.2% for the mobile app. Pathway implementation seemed to be positively experienced by physicians and the organization. CONCLUSION: Patients were satisfied with a proactive survivorship care pathway, and the majority reported that its components were useful in supporting their needs. This study can inform the implementation of survivorship care pathways in other centers. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

13. Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer

Author

Soldato, Davide, primary, Havas, Julie, additional, Crane, Tracy E., additional, Presti, Daniele, additional, Lapidari, Pietro, additional, Rassy, Nathalie, additional, Pistilli, Barbara, additional, Martin, Elise, additional, Del Mastro, Lucia, additional, Martin, Anne‐Laure, additional, Jacquet, Alexandra, additional, Coutant, Charles, additional, Cottu, Paul, additional, Merimeche, Asma, additional, Lerebours, Florence, additional, Tredan, Olivier, additional, Vanlemmens, Laurence, additional, André, Fabrice, additional, Vaz‐Luis, Ines, additional, and Di Meglio, Antonio, additional

Published
2022
Full Text
View/download PDF

14. 18F-FDG PET–derived parameter total lesion glycolisis (TLG) as a tool to stratify patients (pts) with advanced non–small cell lung cancer (aNSCLC) treated with immunotherapy.

Author

Dall'Olio, Filippo Gustavo, primary, Garcia, Camilo, additional, Ambrosini, Valentina, additional, Tagliamento, Marco, additional, Helissey, Carole, additional, Velasco, Monica, additional, Bettayeb, Mohamed Aymen, additional, Aldea, Mihaela, additional, Conci, Nicole, additional, Bauckneht, Matteo, additional, Bonardel, Gerald, additional, Argalia, Giulia, additional, Soldato, Davide, additional, Cella, Eugenia, additional, Remon Masip, Jordi, additional, Planchard, David, additional, Balleyguier, Corinne, additional, Ardizzoni, Andrea, additional, Barlesi, Fabrice, additional, and Besse, Benjamin, additional

Published
2022
Full Text
View/download PDF

15. Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations.

Author

UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service de chirurgie cardiovasculaire et thoracique, UCL - (SLuc) Service de pneumologie, Cortellini, Alessio, Ricciuti, Biagio, Vaz, Victor R, Soldato, Davide, Alessi, Joao V, Dall'Olio, Filippo G, Banna, Giuseppe L, Muthuramalingam, Sethupathi, Chan, Samuel, Majem, Margarita, Piedra, Aida, Lamberti, Giuseppe, Andrini, Elisa, Addeo, Alfredo, Friedlaender, Alex, Facchinetti, Francesco, Gorría, Teresa, Mezquita, Laura, Hoton, Delphine, Lacroix, Valerie, Aboubakar Nana, Frank, Artingstall, James, Comins, Charles, Di Maio, Massimo, Caglio, Andrea, Cave, Judith, McKenzie, Hayley, Newsom-Davis, Thomas, Evans, Joanne S, Tiseo, Marcello, D'Alessio, Antonio, Fulgenzi, Claudia A M, Besse, Benjamin, Awad, Mark M, Pinato, David J, UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service de chirurgie cardiovasculaire et thoracique, UCL - (SLuc) Service de pneumologie, Cortellini, Alessio, Ricciuti, Biagio, Vaz, Victor R, Soldato, Davide, Alessi, Joao V, Dall'Olio, Filippo G, Banna, Giuseppe L, Muthuramalingam, Sethupathi, Chan, Samuel, Majem, Margarita, Piedra, Aida, Lamberti, Giuseppe, Andrini, Elisa, Addeo, Alfredo, Friedlaender, Alex, Facchinetti, Francesco, Gorría, Teresa, Mezquita, Laura, Hoton, Delphine, Lacroix, Valerie, Aboubakar Nana, Frank, Artingstall, James, Comins, Charles, Di Maio, Massimo, Caglio, Andrea, Cave, Judith, McKenzie, Hayley, Newsom-Davis, Thomas, Evans, Joanne S, Tiseo, Marcello, D'Alessio, Antonio, Fulgenzi, Claudia A M, Besse, Benjamin, Awad, Mark M, and Pinato, David J

Abstract

INTRODUCTION: It has been recognized that increasing body mass index (BMI) is associated with improved outcome from immune checkpoint inhibitors (ICIs) in patients with various malignancies including non-small cell lung cancer (NSCLC). However, it is unclear whether baseline BMI may influence outcomes from first-line chemoimmunotherapy combinations. METHODS: In this international multicenter study, we evaluated the association between baseline BMI, progression-free survival (PFS) and overall survival (OS) in a cohort of patients with stage IV NSCLC consecutively treated with first-line chemoimmunotherapy combinations. BMI was categorized according to WHO criteria. Results: Among the 853 included patients, 5.3% were underweight; 46.4% were of normal weight; 33.8% were overweight; and 14.5% were obese. Overweight and obese patients were more likely aged ≥70 years (p=0.00085), never smokers (p<0.0001), with better baseline Eastern Cooperative Oncology Group-Performance Status (p=0.0127), and had lower prevalence of central nervous system (p=0.0002) and liver metastases (p=0.0395). Univariable analyses showed a significant difference in the median OS across underweight (15.5 months), normal weight (14.6 months), overweight (20.9 months), and obese (16.8 months) patients (log-rank: p=0.045, log rank test for trend: p=0.131), while no difference was found with respect to the median PFS (log-rank for trend: p=0.510). Neither OS nor PFS was significantly associated with baseline BMI on multivariable analysis. CONCLUSIONS: In contrast to what was observed in the context of chemotherapy-free ICI-based regimens, baseline BMI does not affect clinical outcomes from chemoimmunotherapy combinations in patients with advanced NSCLC.

Published
2022

16. Abstract P4-11-09: Cancer-related cognitive impairment (CRCI) in early breast cancer (BC) survivors

Author

Presti, Daniele, primary, Joly, Florence, additional, Soldato, Davide, additional, Christodoulidis, Stergios, additional, Noce, Antonin Della, additional, Havas, Julie, additional, Dubuisson, Florine, additional, Pistilli, Barbara, additional, Camara-Clayette, Valerie, additional, André, Fabrice, additional, Martin, Anne-Laure, additional, Jacquet, Alexandra, additional, Boyault, Sandrine, additional, Bièche, Ivan, additional, Coutant, Charles, additional, Cournede, Paul-Henry, additional, Michiels, Stefan, additional, Pradon, Caroline, additional, Vaz-Luis, Ines, additional, and Meglio, Antonio Di, additional

Published
2022
Full Text
View/download PDF

17. Abstract P4-11-34: An integrated clinical, behavioral and biological model to predict the risk of weight gain among breast cancer survivors (BCS)

Author

Soldato, Davide, primary, Meglio, Antonio Di, additional, Pradon, Caroline, additional, Noce, Antonin Della, additional, Presti, Daniele, additional, Havas, Julie, additional, Dubuisson, Florine, additional, Pistilli, Barbara, additional, Camara-Clayette, Valerie, additional, André, Fabrice, additional, Jacquet, Alexandra, additional, Everhard, Sibille, additional, Boyault, Sandrine, additional, Cournede, Paul-Henry, additional, Michiels, Stefan, additional, Vaz-Luis, Ines, additional, and Christodoulidis, Stergios, additional

Published
2022
Full Text
View/download PDF

18. Abstract P4-11-01: Development of a clinico-bio-behavioral model for cancer-related fatigue (CRF) incorporating inflammatory biomarkers and proteomic data

Author

Meglio, Antonio Di, primary, Christodoulidis, Stergios, additional, Soldato, Davide, additional, Noce, Antonin Della, additional, Presti, Daniele, additional, Havas, Julie, additional, Dubuisson, Florine, additional, Pistilli, Barbara, additional, Camara-Clayette, Valerie, additional, Charles, Cecile, additional, Ganz, Patricia A, additional, Bower, Julienne, additional, Partridge, Ann H, additional, Jacquet, Alexandra, additional, Everhard, Sibille, additional, Boyault, Sandrine, additional, André, Fabrice, additional, Cournede, Paul-Henry, additional, Michiels, Stefan, additional, Pradon, Caroline, additional, and Vaz-Luis, Ines, additional

Published
2022
Full Text
View/download PDF

19. Abstract P4-11-27: A multimodal and personalized digital companion to help survivors of breast cancer (BC) manage side effects of adjuvant endocrine therapy (ET): A qualitative exploration

Author

Martin, Elise, primary, Meglio, Antonio Di, additional, Lapidari, Pietro, additional, Presti, Daniele, additional, Soldato, Davide, additional, Degousee, Léna, additional, Aupomerol, Marion, additional, Pistilli, Barbara, additional, Fasse, Léonor, additional, Boinon, Diane, additional, Scotte, Florian, additional, Menvielle, Gwenn, additional, Dumas, Agnès, additional, Lazorthes, Céline, additional, Benhamou, Jonathan, additional, Pozza, Matthieu, additional, Martin-Neuville, Raphaëlle, additional, Helleringer, Nicolas, additional, Eelkema, Jeanne, additional, Andre, Fabrice, additional, Vaz-Luis, Ines, additional, and Franzoi, Maria Alice, additional

Published
2022
Full Text
View/download PDF

20. Abstract P3-12-12: ATTITUDE: Understanding and reducing ATTrition in longiTUDinal studiEs of cancer survivors

Author

Lapidari, Pietro, primary, Havas, Julie, additional, Presti, Daniele, additional, Soldato, Davide, additional, Martin, Elise, additional, Pistilli, Barbara, additional, Bertaut, Aurelie, additional, Boinon, Diane, additional, Jacob, Guillemette, additional, Martin, Anne-Laure, additional, Everhard, Sibille, additional, Jacquet, Alexandra, additional, Menvielle, Gwenn, additional, Lambertini, Matteo, additional, Vanlemmens, Laurence, additional, Michiels, Stefan, additional, André, Fabrice, additional, Vaz-Luis, Ines, additional, and Di Meglio, Antonio, additional

Published
2022
Full Text
View/download PDF

21. Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations

Author

Cortellini, Alessio, primary, Ricciuti, Biagio, additional, Vaz, Victor R, additional, Soldato, Davide, additional, Alessi, Joao V, additional, Dall’Olio, Filippo G, additional, Banna, Giuseppe L, additional, Muthuramalingam, Sethupathi, additional, Chan, Samuel, additional, Majem, Margarita, additional, Piedra, Aida, additional, Lamberti, Giuseppe, additional, Andrini, Elisa, additional, Addeo, Alfredo, additional, Friedlaender, Alex, additional, Facchinetti, Francesco, additional, Gorría, Teresa, additional, Mezquita, Laura, additional, Hoton, Delphine, additional, Valerie, Lacroix, additional, Nana, Frank Aboubakar, additional, Artingstall, James, additional, Comins, Charles, additional, Di Maio, Massimo, additional, Caglio, Andrea, additional, Cave, Judith, additional, McKenzie, Hayley, additional, Newsom-Davis, Thomas, additional, Evans, Joanne S, additional, Tiseo, Marcello, additional, D'Alessio, Antonio, additional, Fulgenzi, Claudia A M, additional, Besse, Benjamin, additional, Awad, Mark M, additional, and Pinato, David J, additional

Published
2022
Full Text
View/download PDF

23. De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence

Author

Conte, Benedetta, Soldato, Davide, Razeti, Maria Grazia, Fregatti, Piero, de Azambuja, Evandro, Schettini, Francesco, Prat, Aleix, Del Mastro, Lucia, Lambertini, Matteo, Conte, Benedetta, Soldato, Davide, Razeti, Maria Grazia, Fregatti, Piero, de Azambuja, Evandro, Schettini, Francesco, Prat, Aleix, Del Mastro, Lucia, and Lambertini, Matteo

Abstract

Women with metastatic breast cancer remains a heterogeneous group of patients with different prognostic outcomes and therapeutic needs. Young women with de novo metastatic breast cancer (dnMBC) represent a peculiar population with respect to tumor biology, prognosis, clinical management and survivorship issues. Overall, these patients are able to attain long-term survival with a proper management of both primary tumor and distant metastases. On the other hand, they are also at higher risk of experiencing a deterioration in their quality of life (QoL) due to primary cancer-related side effects. Young women are also likely to harbor germline pathogenic variants in cancer predisposition genes which could affect treatment decisions and have a direct impact on the lives of patients’ relatives. The loco-regional management of the primary tumor represents another thorny subject, as the surgical approach has shown controversial effects on the survival and the QoL of these patients. This review aims to provide an update on these issues to better inform the clinical management of dnMBC in young women., SCOPUS: ar.j, info:eu-repo/semantics/published

Published
2021

24. BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications

Author

Messina, Carlo, Cattrini, Carlo, Soldato, Davide, Vallome, Giacomo, Caffo, Orazio, Castro, Elena, Olmos, David, Boccardo, Francesco, and Zanardi, Elisa

Subjects
Article Subject
Abstract

Despite chemotherapy and novel androgen-receptor signalling inhibitors (ARSi) have been approved during the last decades, metastatic castration-resistant prostate cancer (mCRPC) remains a lethal disease with poor clinical outcomes. Several studies found that germline or acquired DNA damage repair (DDR) defects affect a high percentage of mCRPC patients. Among DDR defects, BRCA mutations show relevant clinical implications. BRCA mutations are associated with adverse clinical features in primary tumors and with poor outcomes in patients with mCRPC. In addition, BRCA mutations predict good response to poly-ADP ribose polymerase (PARP) inhibitors, such as olaparib, rucaparib, and niraparib. However, concerns still remain on the role of extensive mutational testing in prostate cancer patients, given the implications for patients and for their progeny. The present comprehensive review attempts to provide an overview of BRCA mutations in prostate cancer, focusing on their prognostic and predictive roles.

Published
2020
Full Text
View/download PDF

25. Management of Phylloid Sarcomas: A Retrospective Study of 12 Cases

Author

Ka, Kanta, primary, Bague, Abdoul Halim, additional, Mounkeila, Ibrahim, additional, Foba, Mamadou Lassana, additional, Zongo, N., additional, Soldato, Davide, additional, Dall’Olio, Filippo, additional, Dieng, Mamadou Moustapha, additional, Gaye, Papa Macoumba, additional, and Presti, Daniele, additional

Published
2021
Full Text
View/download PDF

26. Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis

Author

Vaz-Luis, Ines, primary, Di Meglio, Antonio, additional, Havas, Julie, additional, El-Mouhebb, Mayssam, additional, Lapidari, Pietro, additional, Presti, Daniele, additional, Soldato, Davide, additional, Pistilli, Barbara, additional, Dumas, Agnes, additional, Menvielle, Gwenn, additional, Charles, Cecile, additional, Everhard, Sibille, additional, Martin, Anne-Laure, additional, Cottu, Paul Henri, additional, Lerebours, Florence, additional, Coutant, Charles, additional, Dauchy, Sarah, additional, Delaloge, Suzette, additional, Lin, Nancy, additional, Ganz, Patricia Anne, additional, Partridge, Ann H., additional, André, Fabrice, additional, and Michiels, Stefan, additional

Published
2021
Full Text
View/download PDF

27. Update on the Management of Breast Cancer during Pregnancy

Author

Poggio, Francesca, primary, Tagliamento, Marco, additional, Pirrone, Chiara, additional, Soldato, Davide, additional, Conte, Benedetta, additional, Molinelli, Chiara, additional, Cosso, Maurizio, additional, Fregatti, Piero, additional, Del Mastro, Lucia, additional, and Lambertini, Matteo, additional

Published
2020
Full Text
View/download PDF

28. Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)

Author

Puccini, Alberto, primary, Poorman, Kelsey, additional, Salem, Mohamed E., additional, Soldato, Davide, additional, Seeber, Andreas, additional, Goldberg, Richard M., additional, Shields, Anthony F., additional, Xiu, Joanne, additional, Battaglin, Francesca, additional, Berger, Martin D., additional, Tokunaga, Ryuma, additional, Naseem, Madiha, additional, Barzi, Afsaneh, additional, Iqbal, Syma, additional, Zhang, Wu, additional, Soni, Shivani, additional, Hwang, Jimmy J., additional, Philip, Philip A., additional, Sciallero, Stefania, additional, Korn, W. Michael, additional, Marshall, John L., additional, and Lenz, Heinz-Josef, additional

Published
2020
Full Text
View/download PDF

31. Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients

Author

Arecco, Luca, primary, Perachino, Marta, additional, Damassi, Alessandra, additional, Latocca, Maria Maddalena, additional, Soldato, Davide, additional, Vallome, Giacomo, additional, Parisi, Francesca, additional, Razeti, Maria Grazia, additional, Solinas, Cinzia, additional, Tagliamento, Marco, additional, Spinaci, Stefano, additional, Massarotti, Claudia, additional, and Lambertini, Matteo, additional

Published
2020
Full Text
View/download PDF

33. Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study.

Author

Cattrini, Carlo, primary, Cerbone, Luigi, additional, Rubagotti, Alessandra, additional, Zinoli, Linda, additional, Latocca, Maria Maddalena, additional, Buzzatti, Giulia, additional, Vallome, Giacomo, additional, Rizzo, Fabio, additional, Cavo, Alessia, additional, Beshiri, Kristi, additional, Soldato, Davide, additional, Messina, Carlo, additional, Zanardi, Elisa, additional, and Boccardo, Francesco, additional

Published
2018
Full Text
View/download PDF

34. Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients

Author

Morgese, Francesca, primary, Soldato, Davide, additional, Pagliaretta, Silvia, additional, Giampieri, Riccardo, additional, Brancorsini, Donatella, additional, Torniai, Mariangela, additional, Rinaldi, Silvia, additional, Savini, Agnese, additional, Onofri, Azzurra, additional, Scarpelli, Marina, additional, and Berardi, Rossana, additional

Published
2017
Full Text
View/download PDF

35. Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

Author

Hirsh, Vera, primary, Pignata, Sandro, additional, Bersanelli, Melissa, additional, Gnetti, Letizia, additional, Azzoni, Cinzia, additional, Bottarelli, Lorena, additional, Gasparro, Donatello, additional, Leonardi, Francesco, additional, Silini, Enrico Maria, additional, Buti, Sebastiano, additional, Wennerberg, Erik, additional, Mediero, Aranzazu, additional, Cronstein, Bruce, additional, Formenti, Silvia, additional, Demaria, Sandra, additional, Vanpouille-Box, Claire, additional, Pilones, Karsten, additional, Rudqvist, Nils, additional, Diamond, Julie, additional, Morris, Zachary S., additional, Guy, Emily I., additional, Francis, David M., additional, Gressett, Monica M., additional, Armstrong, Eric A., additional, Huang, Shyhmin, additional, Gilles, Stephen D., additional, Korman, Alan J., additional, Hank, Jacquelyn A., additional, Hoefges, Anna, additional, Rakhmilevich, Alexander L., additional, Harari, Paul M., additional, Sondel, Paul M., additional, Hailemichael, Yared, additional, Overwijk, Willem W., additional, Straten, Per thor, additional, Lugli, Alessandro, additional, Dawson, Heather, additional, Blank, Annika, additional, Zlobec, Inti, additional, Fattore, Luigi, additional, Costantini, Susan, additional, Acunzo, Mario, additional, Romano, Giulia, additional, Nigita, Giovanni, additional, Laganà, Alessandro, additional, Malpicci, Debora, additional, Ruggiero, Ciro Francesco, additional, Pisanu, Maria Elena, additional, Noto, Alessia, additional, De Vitis, Claudia, additional, Croce, Carlo Maria, additional, Ascierto, Paolo Antonio, additional, Mancini, Rita, additional, Ciliberto, Gennaro, additional, Postow, Michael, additional, Luke, Jason, additional, Stroncek, David, additional, Castiello, Luciano, additional, Chen, Wenjing, additional, Jin, Ping, additional, Ren, Jiaqiang, additional, Sabatino, Marianna, additional, Ferrone, Soldano, additional, Duong, Connie PM, additional, Vetizou, Marie, additional, Zitvogel, Laurence, additional, Occelli, Marcella, additional, Cauchi, Carolina, additional, Sciancalepore, Grazia, additional, Lo Nigro, Cristiana, additional, Rovera, Michela, additional, Varamo, Chiara, additional, Vivenza, Daniela, additional, Seia, Zelda, additional, Palazzini, Stefania, additional, Errico, Fabiana, additional, Basso, Davide, additional, Quaranta, Laura, additional, Forte, Giuseppe, additional, Lavagna, Fulvio, additional, Violante, Silvia, additional, Bosio, Paolo, additional, Lattanzio, Laura, additional, Merlano, Marco Carlo, additional, Moogk, Duane, additional, Zhong, Shi, additional, Yu, Zhiya, additional, Liadi, Ivan, additional, Rittase, William, additional, Fang, Victoria, additional, Dougherty, Janna, additional, Perez-Garcia, Arianne, additional, Osman, Iman, additional, Zhu, Cheng, additional, Varadarajan, Navin, additional, Restifo, Nicholas P., additional, Frey, Alan, additional, Krogsgaard, Michelle, additional, Balatoni, Timea, additional, Moho, Anita, additional, Sebestyén, Timea, additional, Varga, Anita, additional, Oláh, Judit, additional, Lengyel, Zsuzsanna, additional, Emri, Gabriella, additional, Liszkay, Gabriella, additional, Ladányi, Andrea, additional, Polini, Beatrice, additional, Fogli, Stefano, additional, Carpi, Sara, additional, Pardini, Barbara, additional, Naccarati, Alessio, additional, Dubbini, Nevio, additional, Breschi, Maria Cristina, additional, Romanini, Antonella, additional, Nieri, Paola, additional, Morgese, Francesca, additional, Soldato, Davide, additional, Pagliaretta, Silvia, additional, Giampieri, Riccardo, additional, Brancorsini, Donatella, additional, Rinaldi, Silvia, additional, Torniai, Mariangela, additional, Campanati, Anna, additional, Ganzetti, Giulia, additional, Offidani, Annamaria, additional, Giacchetti, Alfredo, additional, Ricotti, Giuseppe, additional, Savini, Agnese, additional, Onofri, Azzurra, additional, Bianchi, Francesca, additional, Berardi, Rossana, additional, Galdo, Giovanna, additional, Orlandino, Gianfranco, additional, Serio, Salvatore, additional, Massariello, Domenico, additional, Fabrizio, Tommaso, additional, Montagnani, Valentina, additional, Benelli, Matteo, additional, Apollo, Alessandro, additional, Pescucci, Chiara, additional, Licastro, Danilo, additional, Urso, Carmelo, additional, Gerlini, Gianni, additional, Borgognoni, Lorenzo, additional, Luzzatto, Lucio, additional, Stecca, Barbara, additional, Gambale, Elisabetta, additional, Tinari, Camilla, additional, Quinzii, Alberto, additional, Cortellini, Alessio, additional, Carella, Consiglia, additional, De Tursi, Michele, additional, De Francesco, Adele Emanuela, additional, De Fina, Mariarosanna, additional, Zito, Maria Cristina, additional, Bisceglia, Maria Dezia, additional, Esposito, Stefania, additional, Fersini, Giuseppina, additional, Morello, Silvana, additional, Sorrentino, Claudia, additional, Pinto, Aldo, additional, Di Sarno, Antonella, additional, Bianco, Antonella, additional, D’Aniello, Carmine, additional, Andreozzi, Francesca, additional, Festina, Lucia, additional, Vanella, Vito, additional, Montesarchio, Vincenzo, additional, Kotlan, Beatrix, additional, Godeny, Maria, additional, Emil, Farkas, additional, Toth, Laszlo, additional, Horvath, Szabolcs, additional, Eles, Klara, additional, Savolt, Akos, additional, Szollar, Andras, additional, Kasler, Miklós, additional, Yiu, Daniel, additional, Grizzi, Fabio, additional, Patrinicola, Federica, additional, Chiriva-Internati, Maurizio, additional, Motta, Stefania, additional, Monti, Marcello, additional, Benini, Lavinia, additional, Ugel, Stefano, additional, Cingarlini, Sara, additional, Fiore, Alessandra, additional, Grego, Elisabetta, additional, Tortora, Giampaolo, additional, Bronte, Vincenzo, additional, Tondulli, Luca, additional, Di Monta, Gianluca, additional, Caracò, Corrado, additional, Marone, Ugo, additional, Festino, Lucia, additional, and Mozzillo, Nicola, additional

Published
2017
Full Text
View/download PDF

36. Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five mammella interGruppo (MIG) and gruppo italiano mammella (GIM) randomized clinical trials (RCTs).

Author

Soldato, Davide, Blondeaux, Eva, Bruzzone, Marco, Mura, Silvia, De Laurentiis, Michelino, Turletti, Anna, De Placido, Sabino, Bisagni, Giancarlo, Rimanti, Anita, Michelotti, Andrea, Fabi, Alessandra, Russo, Antonio, Gori, Stefania, Durando, Antonio, Nader Marta, Guilherme, de Azambuja, Evandro, Di Meglio, Antonio, Vaz-Luis, Ines, Lambertini, Matteo, and Del Mastro, Lucia

Published
2023
Full Text
View/download PDF

37. Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

Author

Hirsh, Vera, Pignata, Sandro, Bersanelli, Melissa, Gnetti, Letizia, Azzoni, Cinzia, Bottarelli, Lorena, Gasparro, Donatello, Leonardi, Francesco, Silini, Enrico Maria, Buti, Sebastiano, Wennerberg, Erik, Mediero, Aranzazu, Cronstein, Bruce, Formenti, Silvia, Demaria, Sandra, Vanpouille-Box, Claire, Pilones, Karsten, Rudqvist, Nils, Diamond, Julie, Morris, Zachary S., Guy, Emily I., Francis, David M., Gressett, Monica M., Armstrong, Eric A., Huang, Shyhmin, Gilles, Stephen D., Korman, Alan J., Hank, Jacquelyn A., Hoefges, Anna, Rakhmilevich, Alexander L., Harari, Paul M., Sondel, Paul M., Hailemichael, Yared, Overwijk, Willem W., Straten, Per thor, Lugli, Alessandro, Dawson, Heather, Blank, Annika, Zlobec, Inti, Fattore, Luigi, Costantini, Susan, Acunzo, Mario, Romano, Giulia, Nigita, Giovanni, Laganà, Alessandro, Malpicci, Debora, Ruggiero, Ciro Francesco, Pisanu, Maria Elena, Noto, Alessia, De Vitis, Claudia, Croce, Carlo Maria, Ascierto, Paolo Antonio, Mancini, Rita, Ciliberto, Gennaro, Postow, Michael, Luke, Jason, Stroncek, David, Castiello, Luciano, Chen, Wenjing, Jin, Ping, Ren, Jiaqiang, Sabatino, Marianna, Ferrone, Soldano, Duong, Connie PM, Vetizou, Marie, Zitvogel, Laurence, Occelli, Marcella, Cauchi, Carolina, Sciancalepore, Grazia, Lo Nigro, Cristiana, Rovera, Michela, Varamo, Chiara, Vivenza, Daniela, Seia, Zelda, Palazzini, Stefania, Errico, Fabiana, Basso, Davide, Quaranta, Laura, Forte, Giuseppe, Lavagna, Fulvio, Violante, Silvia, Bosio, Paolo, Lattanzio, Laura, Merlano, Marco Carlo, Moogk, Duane, Zhong, Shi, Yu, Zhiya, Liadi, Ivan, Rittase, William, Fang, Victoria, Dougherty, Janna, Perez-Garcia, Arianne, Osman, Iman, Zhu, Cheng, Varadarajan, Navin, Restifo, Nicholas P., Frey, Alan, Krogsgaard, Michelle, Balatoni, Timea, Moho, Anita, Sebestyén, Timea, Varga, Anita, Oláh, Judit, Lengyel, Zsuzsanna, Emri, Gabriella, Liszkay, Gabriella, Ladányi, Andrea, Polini, Beatrice, Fogli, Stefano, Carpi, Sara, Pardini, Barbara, Naccarati, Alessio, Dubbini, Nevio, Breschi, Maria Cristina, Romanini, Antonella, Nieri, Paola, Morgese, Francesca, Soldato, Davide, Pagliaretta, Silvia, Giampieri, Riccardo, Brancorsini, Donatella, Rinaldi, Silvia, Torniai, Mariangela, Campanati, Anna, Ganzetti, Giulia, Offidani, Annamaria, Giacchetti, Alfredo, Ricotti, Giuseppe, Savini, Agnese, Onofri, Azzurra, Bianchi, Francesca, Berardi, Rossana, Galdo, Giovanna, Orlandino, Gianfranco, Serio, Salvatore, Massariello, Domenico, Fabrizio, Tommaso, Montagnani, Valentina, Benelli, Matteo, Apollo, Alessandro, Pescucci, Chiara, Licastro, Danilo, Urso, Carmelo, Gerlini, Gianni, Borgognoni, Lorenzo, Luzzatto, Lucio, Stecca, Barbara, Gambale, Elisabetta, Tinari, Camilla, Quinzii, Alberto, Cortellini, Alessio, Carella, Consiglia, De Tursi, Michele, De Francesco, Adele Emanuela, De Fina, Mariarosanna, Zito, Maria Cristina, Bisceglia, Maria Dezia, Esposito, Stefania, Fersini, Giuseppina, Morello, Silvana, Sorrentino, Claudia, Pinto, Aldo, Di Sarno, Antonella, Bianco, Antonella, D’Aniello, Carmine, Andreozzi, Francesca, Festina, Lucia, Vanella, Vito, Montesarchio, Vincenzo, Kotlan, Beatrix, Godeny, Maria, Emil, Farkas, Toth, Laszlo, Horvath, Szabolcs, Eles, Klara, Savolt, Akos, Szollar, Andras, Kasler, Miklós, Yiu, Daniel, Grizzi, Fabio, Patrinicola, Federica, Chiriva-Internati, Maurizio, Motta, Stefania, Monti, Marcello, Benini, Lavinia, Ugel, Stefano, Cingarlini, Sara, Fiore, Alessandra, Grego, Elisabetta, Tortora, Giampaolo, Bronte, Vincenzo, Tondulli, Luca, Di Monta, Gianluca, Caracò, Corrado, Marone, Ugo, Festino, Lucia, and Mozzillo, Nicola

Published
2017
Full Text
View/download PDF

39. Long-term behavioral symptom clusters among survivors of early-stage breast cancer. development and validation of a predictive model.

Author

Pagliuca M, Havas J, Thomas E, Drouet Y, Soldato D, Franzoi MA, Ribeiro J, Chiodi CK, Gillanders E, Pistilli B, Menvielle G, Joly F, Lerebours F, Rigal O, Petit T, Giacchetti S, Dalenc F, Wassermann J, Arsene O, Martin AL, Everhard S, Tredan O, Boyault S, De Laurentiis M, Viari A, Deleuze JF, Bertaut A, André F, Vaz-Luis I, and Di Meglio A

Abstract

Background: Fatigue, cognitive impairment, anxiety, depression, and sleep disturbance are cancer-related behavioral symptoms (CRBS) that may persist years after early-stage breast cancer (BC), affecting quality of life. We aimed at generating a predictive model of long-term CRBS clusters among BC survivors four years post-diagnosis., Methods: Patients with early-stage BC were included from the CANcer TOxicity (NCT01993498). Our outcome was the proportion of patients reporting CRBS clusters four years post-diagnosis (≥3 severe CRBS). Predictors, including clinical, behavioral, and treatment-related characteristics, Behavioral Symptoms Score (BSS; 1 point per severe CRBS at diagnosis) and a pro-inflammatory cytokine (IL-1b, IL-6, TNFα)-genetic risk score, were tested using multivariable logistic regression, implementing bootstrapped Augmented Backwards Elimination. A two-sided p-value < 0.05 defined statistical significance., Results: In the development cohort (N = 3555), 642 patients (19.0%) reported a cluster of CRBS at diagnosis and 755 (21.2%) did so four years post-diagnosis. Younger age (adjusted Odds Ratio [aOR] for 1-year decrement: 1.012; 95% Confidence Interval [CI] 1.003-1.020); previous psychiatric disorders (aOR vs no: 1.27; 95% CI 1.01-1.60); and BSS (aOR ranged from 2.17 [1.66-2.85] for BSS = 1 vs 0 to 12.3 [7.33-20.87] for BSS = 5 vs 0) were predictors of reporting a cluster of CRBS (AUC 0.73 [95%CI 0.71-0.75]). Genetic risk score was not predictive of CRBS. Results were confirmed in the validation cohort (N = 1533)., Conclusion: Younger patients with previous psychiatric disorders and higher baseline symptom burden have greater risk of long-term clusters of CRBS. Our model might be implemented in clinical pathways to improve management and test the effectiveness of risk mitigation interventions among breast cancer survivors., (© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)

Published
2024
Full Text
View/download PDF

40. Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.

Author

Arecco L, Perachino M, Damassi A, Latocca MM, Soldato D, Vallome G, Parisi F, Razeti MG, Solinas C, Tagliamento M, Spinaci S, Massarotti C, and Lambertini M

Abstract

The improved prognosis of breast cancer patients makes survivorship issues an area of crucial importance. In this regard, an increased attention is needed toward the development of potential anticancer treatment-related long-term side-effects, including gonadal failure and infertility in young women. Therefore, fertility preservation and family planning are crucial issues to be addressed in all young women of reproductive age with newly diagnosed cancer. Despite a growing availability of data on the efficacy and safety of fertility preservation options and the fact that conceiving after prior history of breast cancer has become more accepted over time, there are still several gray zones in this field so that many physicians remain uncomfortable to deal with these topics. The purpose of this review is to answer some of the most controversial questions frequently asked by patients during their oncofertility counseling, in order to provide a detailed and up-to-date overview on the evidence available in this field to physicians involved in the care of young women with breast cancer., Competing Interests: Declaration of conflicting interests:The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Matteo Lambertini acted as a consultant for Roche and Novartis, and received honoraria from Theramex, Takeda, Roche, Lilly, Pfizer and Novartis outside the submitted work. All remaining authors declare no conflict of interest., (© The Author(s) 2020.)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results